126 related articles for article (PubMed ID: 38834932)
1. Long-term outcomes and prognosis of neuroendocrine neoplasms of the head and neck: a cohort from a single institution.
Shi X; Huang X; Wang K; Qu Y; Chen X; Wu R; Zhang Y; Zhang J; Luo J; Wang J; Yi J
J Cancer Res Clin Oncol; 2024 Jun; 150(6):288. PubMed ID: 38834932
[TBL] [Abstract][Full Text] [Related]
2. [Outcome and prognostic factors of 125 loco-regionally advanced head and neck squamous cell carcinoma treated with multi-modality treatment].
Qian W; Zhu G; Ji Q; Guo Y; Wang Y; Wang Y
Zhonghua Zhong Liu Za Zhi; 2014 Mar; 36(3):217-22. PubMed ID: 24785284
[TBL] [Abstract][Full Text] [Related]
3. Long-term treatment outcomes and prognosis of mucosal melanoma of the head and neck: 161 cases from a single institution.
Sun S; Huang X; Gao L; Zhang Y; Luo J; Zhang S; Wang K; Qu Y; Wu R; Liu Q; Xiao J; Xu G; Yi J
Oral Oncol; 2017 Nov; 74():115-122. PubMed ID: 29103739
[TBL] [Abstract][Full Text] [Related]
4. Management of nonsinonasal neuroendocrine carcinomas of the head and neck.
Barker JL; Glisson BS; Garden AS; El-Naggar AK; Morrison WH; Ang KK; Chao KS; Clayman G; Rosenthal DI
Cancer; 2003 Dec; 98(11):2322-8. PubMed ID: 14635065
[TBL] [Abstract][Full Text] [Related]
5. Clinical outcomes and patterns of failure of head and neck mucosal melanoma treated with multiple treatment modalities.
Xu QQ; Lai YZ; Huang ZL; Zeng ZY; Zhang YN; Ou RY; Wu WM; Chen L; Lu LX
Radiat Oncol; 2021 Jul; 16(1):138. PubMed ID: 34321026
[TBL] [Abstract][Full Text] [Related]
6. Treatment of squamous cell carcinoma of external auditory canal: A tertiary cancer centre experience.
Gandhi AK; Roy S; Biswas A; Raza MW; Saxena T; Bhasker S; Sharma A; Thakar A; Mohanti BK
Auris Nasus Larynx; 2016 Feb; 43(1):45-9. PubMed ID: 26165629
[TBL] [Abstract][Full Text] [Related]
7. Localized extranodal lymphoma of the head and neck: retrospective analysis of a series of 107 patients from a single institution.
Frata P; Buglione M; Grisanti S; Bonetti B; Vitali E; De Stefani A; Magri E; Peveri A; Marini G; Rossi G; Magrini SM
Tumori; 2005; 91(6):456-62. PubMed ID: 16457141
[TBL] [Abstract][Full Text] [Related]
8. Head and neck squamous cell carcinoma of unknown primary: neck dissection and radiotherapy or definitive radiotherapy.
Demiroz C; Vainshtein JM; Koukourakis GV; Gutfeld O; Prince ME; Bradford CR; Wolf GT; McLean S; Worden FP; Chepeha DB; Schipper MJ; McHugh JB
Head Neck; 2014 Nov; 36(11):1589-1595. PubMed ID: 23996575
[TBL] [Abstract][Full Text] [Related]
9. Neck dissection in the combined-modality therapy of patients with locoregionally advanced head and neck cancer.
Argiris A; Stenson KM; Brockstein BE; Mittal BB; Pelzer H; Kies MS; Jayaram P; Portugal L; Wenig BL; Rosen FR; Haraf DJ; Vokes EE
Head Neck; 2004 May; 26(5):447-55. PubMed ID: 15122662
[TBL] [Abstract][Full Text] [Related]
10. Pattern of care and impact of prognostic factors on the outcome of head and neck extramedullary plasmacytoma: a systematic review and individual patient data analysis of 315 cases.
Venkatesulu B; Mallick S; Giridhar P; Upadhyay AD; Rath GK
Eur Arch Otorhinolaryngol; 2018 Feb; 275(2):595-606. PubMed ID: 29224044
[TBL] [Abstract][Full Text] [Related]
11. Management and Outcome of Ewing Sarcoma of the Head and Neck.
Grevener K; Haveman LM; Ranft A; van den Berg H; Jung S; Ladenstein R; Klco-Brosius S; Juergens H; Merks JH; Dirksen U
Pediatr Blood Cancer; 2016 Apr; 63(4):604-10. PubMed ID: 26702872
[TBL] [Abstract][Full Text] [Related]
12. Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery.
Jin J; Liao Z; Zhang Z; Ajani J; Swisher S; Chang JY; Jeter M; Guerrero T; Stevens CW; Vaporciyan A; Putnam J; Walsh G; Smythe R; Roth J; Yao J; Allen P; Cox JD; Komaki R
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):427-36. PubMed ID: 15380576
[TBL] [Abstract][Full Text] [Related]
13. Randomized trial comparing surgery and adjuvant radiotherapy versus concurrent chemoradiotherapy in patients with advanced, nonmetastatic squamous cell carcinoma of the head and neck: 10-year update and subset analysis.
Iyer NG; Tan DS; Tan VK; Wang W; Hwang J; Tan NC; Sivanandan R; Tan HK; Lim WT; Ang MK; Wee J; Soo KC; Tan EH
Cancer; 2015 May; 121(10):1599-607. PubMed ID: 25639864
[TBL] [Abstract][Full Text] [Related]
14. Patterns of Recurrence in Patients with Stage IIIB/C Cutaneous Melanoma of the Head and Neck Following Surgery With and Without Adjuvant Radiation Therapy: Is Isolated Regional Recurrence Salvageable?
Barbour S; Mark Smithers B; Allan C; Bayley G; Thomas J; Foote M; Burmeister B; Barbour AP
Ann Surg Oncol; 2015 Nov; 22(12):4052-9. PubMed ID: 25582744
[TBL] [Abstract][Full Text] [Related]
15. Phase III randomized trial of preoperative concurrent chemoradiotherapy versus preoperative radiotherapy for patients with locally advanced head and neck squamous cell carcinoma.
Yi J; Huang X; Xu Z; Liu S; Wang X; He X; Luo D; Luo J; Xiao J; Zhang S; Wang K; Qu Y; Tang Y; Liu W; Xu G; Gao L; Wang D
Oncotarget; 2017 Jul; 8(27):44842-44850. PubMed ID: 28179586
[TBL] [Abstract][Full Text] [Related]
16. Adjuvant stereotactic body radiotherapy±cetuximab following salvage surgery in previously irradiated head and neck cancer.
Vargo JA; Kubicek GJ; Ferris RL; Duvvuri U; Johnson JT; Ohr J; Clump DA; Burton S; Heron DE
Laryngoscope; 2014 Jul; 124(7):1579-84. PubMed ID: 24123056
[TBL] [Abstract][Full Text] [Related]
17. Phase III trial of initial chemotherapy in stage III or IV head and neck cancers: a study by the Gruppo di Studio sui Tumori della Testa e del Collo.
Paccagnella A; Orlando A; Marchiori C; Zorat PL; Cavaniglia G; Sileni VC; Jirillo A; Tomio L; Fila G; Fede A
J Natl Cancer Inst; 1994 Feb; 86(4):265-72. PubMed ID: 8158680
[TBL] [Abstract][Full Text] [Related]
18. [Clinical analysis of small cell neuroendocrine carcinoma of the head and neck].
Li ZJ; Li HZ; Liu WS; Xu ZG; Tang PZ
Zhonghua Yi Xue Za Zhi; 2008 Dec; 88(46):3275-8. PubMed ID: 19159554
[TBL] [Abstract][Full Text] [Related]
19. Sequential induction chemotherapy plus intensity-modulated radiotherapy versus concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma: the three-year report of a phase II, single center, randomized, non-inferiority trial.
Yang Z; Cai Z; Cai Q; Hong Y; Zhang C; Huang K; Lin Z; Li M
Cancer Med; 2021 Jun; 10(12):3886-3895. PubMed ID: 33955190
[TBL] [Abstract][Full Text] [Related]
20. Non-metastatic stage IV nasopharyngeal carcinoma patients: analysis of the pattern of relapse and survival.
Ozyar E; Gurkaynak M; Yildiz F; Atahan IL
Radiother Oncol; 2004 Jul; 72(1):71-7. PubMed ID: 15236877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
